Skip to main content

Table 1 Effect of anthocyanins in animal models

From: Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies

Model

Pharmacological effect

References

Rats

↓ SBP

[142–147]

Vasodilation

[148–152]

↓ Total cholesterol

[153, 156]

↓ LDL

[154, 156, 158]

↓ VLDL

[154]

↑ HDL

[154, 155]

↓ Total triglycerides

[153, 156–158]

↑ PUFA

[153]

↓ MDA

[154]

↓ GSH

[155]

↓ Lipid peroxidation

[155]

Mice

↓ Total cholesterol

[147, 162–165]

↓ LDL

[163]

↑ HDL

[163, 164]

↓ Total triglycerides

[147, 164, 165]

↓ Lipid peroxidation

[163]

↓ Atherosclerotic lesions

[161, 166]

↓ TNF-α

[166]

↓ NF-κB

[166]

Rabbits

↓ Total cholesterol

[170]

↓ LDL

[170]

↑ LDL

[169, 172]

↓ VLDL

[169]

↑ HDL

[170, 171]

↓ Total triglycerides

[172]

↓ MDA

[168]

↓ CRP

[170]

↓ GSH

[170, 172]

↑ ApoE

[170]

↓ Atherosclerotic lesions

[172]

  1. SBP systolic blood pressure, PUFA polyunsaturated fatty acids, LDL low-density lipoprotein, VLDL very low density lipoprotein, HDL high-density lipoprotein, MDA malondialdehyde, CRP C-reactive protein, GSH glutathione, ApoE apolipoprotein E, TNF-α tumor necrosis factor-α